2018 American Transplant Congress

Tuesday, June 5, 2018

3:42pm-3:54pm

No Kidney Left Behind: Are We Maximizing Utilization of Deceased Donors with AKI?

A. Bongu, R. Quillin, M. Chiles, S. Husain, M. Garcia, S. Mohan, L. Ratner.

Concurrent Session: Kidney Deceased Donor Allocation - 2  •  Room 6E

3:42pm-3:54pm

Origin and Pattern of Human Polyomaviruses Replication after Kidney Transplantation: A Prospective Study

E. Favi,¹ S. Delbue,² C. Colico,¹ P. Ferrante,² S. Villani,² I. Perna,² N. Mondoni,² A. Giussani,¹ L. Clementoni,¹ P. Messa,³ M. Ferraresso.¹

Concurrent Session: Kidney: Polyoma  •  Room 2AB

3:42pm-3:54pm

Program-Specific Survival from Listing: Variability and Association with Pretransplant and Posttransplant Metrics

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 2  •  Room 4C-4

3:42pm-3:54pm

Trends in Liver Transplantation with Older Liver Donors in the United States

C. Haugen, X. Luo, A. Thomas, C. Holscher, J. Garonzik-Wang, M. McAdams-DeMarco, D. Segev.

Concurrent Session: Donor Management: All Organs Excluding Kidney  •  Room 3AB

3:42pm-3:54pm

What Deceased Donors Do KPD Candidates Accept?

A. Toll,¹ R. Leishman,¹ V. Casingal,² M. Aeder,³ T. Sandholm,⁴ N. Turgeon.⁵

Concurrent Session: Kidney Paired Exchange  •  Room 4B

4:30pm-4:42pm

Dialysis Modality, Inflammation, and Frailty in Kidney Transplant Candidates

P. Shrestha, H. Ying, M. McAdams DeMarco, D. Segev.

Concurrent Session: Kidney: Perioperative Considerations  •  Room 303

4:30pm-4:42pm

Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

J. Assaker,¹ A. Srivastava,¹ J. Hurley,² B. Al Doujailan,¹ S. Eskandari,¹ C. Coticchia,² M. Mohamed,¹ S. Bentink,² V. Tadigotla,² L. Riella,¹ A. Chandraker,¹ J. Skog,² J. Azzi.¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical  •  Room 602/603/604

4:30pm-4:42pm

Genome Wide Non-HLA Alloimmunity Contributes to Graft Loss after Kidney Transplantation

R. Reindl-Schwaighofer, A. Heinzel, A. Kainz, K. Jelencsics, O. Viklicky, G. Böhmig, G. Fischer, B. Keating, R. Oberbauer.

Concurrent Session: Kidney Complications: Antibody & Late Outcomes  •  Room 4B

4:30pm-4:42pm

HIV, HBV, and HCV Screening with NAT and Serology in the OPO Setting

N. Theodoropoulos,¹ M. Ison.²

Concurrent Session: New Frontiers in HIV and Hepatitis  •  Room 4C-3

4:30pm-4:42pm

HO-1 Regulates SIRT1– Autophagy Pathway in Liver Transplantation: From Mouse-to-Human

K. Nakamura,¹ S. Kageyama,¹ S. Yue,¹ A. Aziz,¹ T. Ito,¹ D. Oncel,¹ B. Ke,¹ R. Sosa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹

Concurrent Session: Cellular Therapies and to Promote Tolerance  •  Room 606/607